The announcement of worse-than-expected Q1 financial results typically leads to a negative reaction in the stock market as investors adjust their expectations based on the new information. Given that this news directly pertains to Aquestive Therapeutics' financial performance, it is highly relevant and important to investors, leading to a likely decrease in share price in the short term.